For the record, if there is a recordA brand name pharma closes the apparent " unwilling or unable" deal 85-95% of the time. An unknown Canadian mini biotech from French Canada, maybe not so much. We should all hope that there is a bidding war for the clinching kick. The lifelong die hard here would be well served to wake up to this reality. Don't worry, if MCNA is an approvable proposition they will pay. If not, it will be another run up, swing and a miss. Maybe?